Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), ...

Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA) protein head. The ...

Scientists have identified a new pair of antibodies that could fend off multiple COVID-19 variants. Found in people who successfully recovered from the illness, these antibodies attach to a part of ...

Riliprubart is being evaluated in a phase 2 trial for the prevention and treatment of antibody-mediated rejection. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...